Published in Acta Psychiatr Scand on November 12, 2011
Measuring psychotic depression. Acta Psychiatr Scand (2013) 1.52
Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant. Ther Adv Psychopharmacol (2016) 0.78
Subjective positive well-being. World Psychiatry (2012) 0.75
From Randomized Controlled Trials of Antidepressant Drugs to the Meta-Analytic Synthesis of Evidence: Methodological Aspects Lead to Discrepant Findings. Curr Neuropharmacol (2015) 0.75
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med (2000) 10.25
Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry (1991) 8.37
The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med (1996) 7.70
Implementing evidence-based practices for persons with severe mental illnesses. Psychiatr Serv (2001) 4.93
Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA (1998) 4.48
The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res (1986) 4.16
Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo. Mol Psychiatry (2008) 3.85
A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry (1997) 3.71
Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol (1996) 3.28
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry (1998) 3.27
Flexible treatment strategies in chronic disease: clinical and research implications. Biol Psychiatry (2000) 3.21
A new population-enrichment strategy to improve efficiency of placebo-controlled clinical trials of antidepressant drugs. Clin Pharmacol Ther (2010) 2.74
Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA (1994) 2.74
Physical activity dose-response effects on outcomes of depression and anxiety. Med Sci Sports Exerc (2001) 2.73
The Texas Medication Algorithm Project: development and implementation of the schizophrenia algorithm. Psychiatr Serv (1999) 2.68
Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med (1997) 2.62
Methods to improve diagnostic accuracy in a community mental health setting. Am J Psychiatry (2000) 2.52
Diabetes and postoperative endophthalmitis in the endophthalmitis vitrectomy study. Arch Ophthalmol (2001) 2.49
Redefining the role of psychiatry in medicine. Am J Psychiatry (1996) 2.45
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. J Affect Disord (2001) 2.43
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry (2001) 2.38
When at first you don't succeed: sequential strategies for antidepressant nonresponders. J Clin Psychiatry (1997) 2.35
Treating major depression in primary care practice: an update of the Agency for Health Care Policy and Research Practice Guidelines. Arch Gen Psychiatry (1998) 2.23
Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry (1999) 2.23
ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE. J ECT (2001) 2.21
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry (1998) 2.13
Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment. Am J Psychiatry (1998) 2.12
Onset and persistence of postpartum depression in an inner-city maternal health clinic system. Am J Psychiatry (2001) 1.93
Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. Psychol Med (2009) 1.91
Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biol Psychiatry (2001) 1.88
The Texas Medication Algorithm Project: report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder. J Clin Psychiatry (1999) 1.84
Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model. Psychol Med (2011) 1.83
Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury. Crit Care Med (2000) 1.82
Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry (1995) 1.73
Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis. Psychol Med (2010) 1.71
A placebo-controlled, randomized clinical trial comparing sertraline and imipramine for the treatment of dysthymia. Arch Gen Psychiatry (1996) 1.71
Vagus nerve stimulation: a new tool for brain research and therapy. Biol Psychiatry (2000) 1.69
Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder. Acta Psychiatr Scand (2009) 1.67
Workplace performance effects from chronic depression and its treatment. J Health Econ (1998) 1.66
Microbiologic yields and complication rates of vitreous needle aspiration versus mechanized vitreous biopsy in the Endophthalmitis Vitrectomy Study. Retina (1999) 1.63
Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol Psychiatry (2000) 1.60
Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry (2006) 1.58
Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: a survey of clinicians. Can J Psychiatry (2000) 1.57
Influence of legume intake on biliary lipids and cholesterol saturation in young Chilean men. Identification of a dietary risk factor for cholesterol gallstone formation in a highly prevalent area. Gastroenterology (1989) 1.55
Quinolinic acid in the cerebrospinal fluid of children after traumatic brain injury. Crit Care Med (1999) 1.53
The influence of age on the response of major depression to electroconvulsive therapy: a C.O.R.E. Report. Am J Geriatr Psychiatry (2001) 1.53
Increased adenosine in cerebrospinal fluid after severe traumatic brain injury in infants and children: association with severity of injury and excitotoxicity. Crit Care Med (2001) 1.52
Development of a brief screening instrument: the HANDS. Psychother Psychosom (2000) 1.51
Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology (2001) 1.51
Excitatory amino acid concentrations in ventricular cerebrospinal fluid after severe traumatic brain injury in infants and children: the role of child abuse. J Pediatr (2001) 1.50
Gender differences in personality disorders. Am J Psychiatry (1995) 1.48
Well-being, appraisal, and coping in African-American and Caucasian dementia caregivers: findings from the REACH study. Aging Ment Health (2004) 1.47
No long-term benefit from hypothermia after severe traumatic brain injury with secondary insult in rats. Crit Care Med (2000) 1.46
Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. Arch Neurol (1999) 1.45
Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. J Affect Disord (1999) 1.45
[Mechanical fragmentation and intrapulmonary fibrinolysis in the treatment of massive pulmonary embolism hemodynamic repercussions]. Arch Bronconeumol (2001) 1.44
Depressed outpatients treated with cognitive therapy or pharmacotherapy. A one-year follow-up. Arch Gen Psychiatry (1981) 1.41
Lactate infusion induces panic attacks in patients with premenstrual syndrome. Psychosom Med (1992) 1.41
Perceptual asymmetry, plasma cortisol, and response to treatment in depressed outpatients. Biol Psychiatry (1991) 1.40
Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study. Arch Ophthalmol (1997) 1.40
A cross-sectional study of private psychiatric practices under a single-payer health care system. Can J Psychiatry (1997) 1.39
Interruption of selective serotonin reuptake inhibitor treatment. Double-blind, placebo-controlled trial. Br J Psychiatry (2000) 1.37
A detailed examination of cytokine abnormalities in Major Depressive Disorder. Eur Neuropsychopharmacol (2007) 1.36
Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children. J Neurotrauma (1997) 1.36
Cerebrovascular response in infants and young children following severe traumatic brain injury: a preliminary report. Pediatr Neurosurg (1997) 1.33
SLC6A4 variation and citalopram response. Am J Med Genet B Neuropsychiatr Genet (2009) 1.32
Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: a proof of concept. Transl Psychiatry (2011) 1.32
Timing of onset of antidepressant response with fluoxetine treatment. Am J Psychiatry (2000) 1.30
The importance of irritability as a symptom of major depressive disorder: results from the National Comorbidity Survey Replication. Mol Psychiatry (2009) 1.29
Fluoxetine in child and adolescent depression: acute and maintenance treatment. Depress Anxiety (1998) 1.28
Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. Acta Psychiatr Scand (2005) 1.27
Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology (1999) 1.27
Improving the prediction of treatment response in depression: integration of clinical, cognitive, psychophysiological, neuroimaging, and genetic measures. CNS Spectr (2008) 1.25
Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness. Psychol Med (2000) 1.24
MAOIs in the contemporary treatment of depression. Neuropsychopharmacology (1995) 1.23
Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry (2000) 1.22
Inducible nitric oxide synthase is an endogenous neuroprotectant after traumatic brain injury in rats and mice. J Clin Invest (1999) 1.21
Benzodiazepines as antidepressants: does GABA play a role in depression? Biol Psychiatry (1995) 1.21
Retinal detachment in the endophthalmitis vitrectomy study. Arch Ophthalmol (2000) 1.20
Slow-wave activity in NREM sleep: sex and age effects in depressed outpatients and healthy controls. Psychiatry Res (2000) 1.20
Relationship between objective and subjective sleep measures in depressed patients and healthy controls. Depress Anxiety (1997) 1.19
The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum. Ophthalmology (1997) 1.18
Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Mol Psychiatry (2012) 1.17
The Texas Medication Algorithm Project (TMAP) schizophrenia algorithms. J Clin Psychiatry (1999) 1.17
Prevalence and clinical features of body dysmorphic disorder in atypical major depression. J Nerv Ment Dis (1996) 1.16
Is there a role for continuation phase cognitive therapy for depressed outpatients? J Consult Clin Psychol (1998) 1.16
Short-term psychotherapy of depressive disorders: current status and future directions. Psychiatry (1994) 1.15
Sensitivity of the six-item Hamilton Depression Rating Scale. Acta Psychiatr Scand (1997) 1.15